The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cediranib in combination with olaparib in patients without a germline BRCA1/2 mutation with recurrent platinum-resistant ovarian cancer: Phase IIb CONCERTO trial.
 
Jung-Min Lee
Research Funding - AstraZeneca (Inst); Lilly (Inst)
 
Richard G. Moore
Honoraria - Fujirebio Diagnostics
Consulting or Advisory Role - Abcodia; Fujirebio Diagnostics
Research Funding - Angle
 
Sharad A. Ghamande
Consulting or Advisory Role - Seagen
Speakers' Bureau - Tesaro/GSK
Research Funding - Site PI, GSK/Merck/Roche/Genetech/Takeda/Seattle genetics/Advaxis/BMS/Clovis/Abbvie/Tesaro
 
Min S. Park
Stock and Other Ownership Interests - Abbvie (I); Johnson & Johnson (I); Merck (I); Pfizer (I)
Consulting or Advisory Role - Tempus
 
John Paul Diaz
Speakers' Bureau - AstraZeneca
 
Julia A. Chapman
Speakers' Bureau - Merck
 
James Erasmus Kendrick
No Relationships to Disclose
 
Brian M. Slomovitz
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Genentech; GlaxoSmithKline; Merck
Research Funding - Agenus; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Merck; Novartis
 
Krishnansu Sujata Tewari
Honoraria - Clovis Oncology; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Roche/Genentech; Tesaro
Speakers' Bureau - AstraZeneca; Clovis Oncology; Merck; Roche/Genentech; Tesaro
Research Funding - Abbvie (Inst); Genentech/Roche (Inst); Merck (Inst); Morphotek (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Elizabeth S. Lowe
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Tsveta Milenkova
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Sanjeev Kumar
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Mike Dymond
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Iwanka Kozarewa
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Joyce F. Liu
Consulting or Advisory Role - Clovis Oncology; Genentech/Roche; GlaxoSmithKline; Mersana; Tesaro
Research Funding - 2X Oncology (Inst); Acetylon Pharmaceuticals (Inst); Agenus (Inst); Aravive (Inst); Arch Oncology (Inst); AstraZeneca (Inst); Atara Biotherapeutics (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); CytomX Therapeutics (Inst); Genentech/Roche (Inst); Regeneron (Inst); Surface Oncology (Inst); Tesaro (Inst); Vigeo Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Merck
(OPTIONAL) Uncompensated Relationships - AstraZeneca; Merck